Vision (ISSN 2411-5150) is an open-access journal covering human & biological visual systems.
Read our most highly cited papers from 2024–2025 👇
https://t.co/Ud3EQ2YaDM
#VisionScience#OpenAccess#HighlyCited
Thanks Dr.@SarkisianMD! We always love to see our current users interested in our next-gen, dual-pulse femto, the ALLY™ System. Learn how #ALLY is improving OR efficiencies potentially saving 10 min per patient https://t.co/pB1CTRk6et
@OklahomaEye@aao_ophth#LENSAR
We will be attending the annual #ASCRS2022 scientific meeting where Dr Steven R. @SarkisianMD will be presenting two year results for #MINIject.
To set up a meeting with us, contact: [email protected]
Find out more: https://t.co/PNDS1mKqdn
"The interventional mindset should represent a shift in our thinking… [Moving] away from medication first, and toward a mindset of addressing the suspected area of outflow resistance.” Thank you, Drs. Blieden, Nguyen and @SarkisianMD for hosting Monday night's workshop! 💫
Glaucoma Physician - The Glaucoma Specialty Loses a Leader https://t.co/lx3FrtZ6PB
I was honored to say a few words about the legacy of my friend Dr. Alan Crandall.
“Magic is a way to study epistemology with consent.”
Penn Jillette
Spoken moments ago during the Michael Marmor Lecture in Ophthalmology and the Arts at the American Academy of Ophthalmology virtual annual meeting.
#AAO2020Virtual
Blessed this week to be first in Oklahoma, and among the first in the USA to implant the Durysta sustained release Bimatoprost implant to treat glaucoma. Lowering eye pressure with no drops, no pain, and no restrictions after! #Durysta
Tuesday June 23, 2020: A banner day at Oklahoma Eye Surgeons! I was the first in Oklahoma, and among the first in the USA to implant the Durysta sustained release Bimatoprost implant. These are exciting times to be an eye surgeon, and a new era for our patients with glaucoma!
“Greater love has no one than this, that someone lay down his life for his friends.”
https://t.co/6WryX5X4lW
We at Oklahoma Eye Surgeons remember those who made the ultimate sacrifice, that we might be free serve others with gladness, creativity, and excellence. #MemorialDay2020
“Final results of the STAR-I trial for #MINIject 2 years after standalone implantation are promising because they show significant, sustained IOP reduction, and a large number of med-free patients longer-term”, explained @ikekahmed, who presented at the #ASCRSVirtualMeeting.
Coming soon....
I will have an eye drop alternative that will change the lives of my patients with glaucoma.
I’m psyched for Oklahoma Eye Surgeons to be part of this revolution in eyecare!!!
https://t.co/1I9E2Ywm1O
Here is the latest case report for Glaucoma Today. I was honored to curate the case and gather a group of top experts to contribute their opinions on how to handle this patient’s difficult problem.
https://t.co/BOF8zreRHl #glaucoma#ophthalmology#glaucomatoday@GlaucomaToday
Read about four-year outcomes of iStent inject by Drs. Richard Lindstrom, Steven Sarkisian, Richard Lewis, John Hovanesian and Lilit Voskanyan published in Clinical Ophthalmology.
@MinnesotaEye@SarkisianMD@DrHovanesian@HarvardEye
https://t.co/2IRqwiAu3J
I’m blessed to be the first in the state of Oklahoma to use Alcon’s new Intrepid Hybrid phaco tip with their new Active Sentry phaco hand piece. This tech allows safety I’ve never thought possible. Kudos to Alcon and thanks for letting me be among the first in the US to use it!
Check out my article in the most recent edition of Glaucoma Today, “Glaucomatous Progression in a Young Patient” https://t.co/be5xzLo9nx #ophthalmology@GlaucomaToday
Dr Sarkisian was honored to be the first in Oklahoma, and one of the first in the country to use the newly redesigned Micro-Pulse probe by Iridex. This probe should be available for others to use in the coming weeks for surgeons who have the G6 laser.